Nomura Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $223M | Buy |
1,024,824
+42
| +0% | +$9.32K | 0.57% | 27 |
|
|
2025
Q4 | $234M | Sell |
1,024,782
-77,737
| -7% | -$17.7M | 0.59% | 22 |
|
|
2025
Q3 | $255M | Sell |
1,102,519
-80,369
| -7% | -$16.4M | 0.67% | 18 |
|
|
2025
Q2 | $220M | Sell |
1,182,888
-65,941
| -5% | -$12.3M | 0.6% | 23 |
|
|
2025
Q1 | $262M | Buy |
1,248,829
+70,360
| +6% | +$13.7M | 0.8% | 18 |
|
|
2024
Q4 | $209M | Buy |
1,178,469
+95,711
| +9% | +$17.6M | 0.63% | 21 |
|
|
2024
Q3 | $214M | Buy |
1,082,758
+103,590
| +11% | +$19.3M | 0.66% | 20 |
|
|
2024
Q2 | $168M | Buy |
979,168
+22,849
| +2% | +$3.78M | 0.57% | 24 |
|
|
2024
Q1 | $174M | Sell |
956,319
-14,435
| -1% | -$2.49M | 0.63% | 22 |
|
|
2023
Q4 | $150M | Buy |
970,754
+12,895
| +1% | +$1.88M | 0.62% | 27 |
|
|
2023
Q3 | $143M | Buy |
957,859
+65,758
| +7% | +$9.65M | 0.67% | 22 |
|
|
2023
Q2 | $120M | Buy |
892,101
+51,320
| +6% | +$7.53M | 0.55% | 33 |
|
|
2023
Q1 | $134M | Buy |
840,781
+31,108
| +4% | +$4.76M | 0.7% | 22 |
|
|
2022
Q4 | $131M | Sell |
809,673
-45,695
| -5% | -$7.01M | 0.76% | 22 |
|
|
2022
Q3 | $115M | Buy |
855,368
+159,480
| +23% | +$22.9M | 0.73% | 21 |
|
|
2022
Q2 | $107M | Sell |
695,888
-15,708
| -2% | -$2.4M | 0.67% | 24 |
|
|
2022
Q1 | $115M | Sell |
711,596
-28,788
| -4% | -$4.18M | 0.63% | 25 |
|
|
2021
Q4 | $100M | Buy |
740,384
+97,243
| +15% | +$11.5M | 0.51% | 32 |
|
|
2021
Q3 | $69.4M | Sell |
643,141
-60,691
| -9% | -$6.93M | 0.39% | 59 |
|
|
2021
Q2 | $79.3M | Buy |
703,832
+15,704
| +2% | +$1.77M | 0.46% | 44 |
|
|
2021
Q1 | $74.5M | Sell |
688,128
-20,702
| -3% | -$2.21M | 0.47% | 42 |
|
|
2020
Q4 | $76M | Buy |
708,830
+94,333
| +15% | +$9.07M | 0.51% | 41 |
|
|
2020
Q3 | $53.8M | Buy |
614,497
+31,519
| +5% | +$2.97M | 0.41% | 54 |
|
|
2020
Q2 | $57.2M | Buy |
582,978
+73,445
| +14% | +$6.47M | 0.48% | 47 |
|
|
2020
Q1 | $38.8M | Buy |
509,533
+59,835
| +13% | +$5.1M | 0.4% | 61 |
|
|
2019
Q4 | $39.8M | Buy |
449,698
+11,889
| +3% | +$987K | 0.36% | 66 |
|
|
2019
Q3 | $33.2M | Buy |
437,809
+47,190
| +12% | +$3.24M | 0.32% | 73 |
|
|
2019
Q2 | $28.4M | Buy |
390,619
+9,649
| +3% | +$758K | 0.28% | 79 |
|
|
2019
Q1 | $30.7M | Buy |
380,970
+3,912
| +1% | +$320K | 0.3% | 79 |
|
|
2018
Q4 | $34.8M | Buy |
377,058
+14,520
| +4% | +$1.28M | 0.39% | 64 |
|
|
2018
Q3 | $34.3M | Buy |
362,538
+14,040
| +4% | +$1.33M | 0.33% | 70 |
|
|
2018
Q2 | $32.3M | Sell |
348,498
-7,085
| -2% | -$692K | 0.34% | 67 |
|
|
2018
Q1 | $33.7M | Buy |
355,583
+28,125
| +9% | +$3.09M | 0.37% | 66 |
|
|
2017
Q4 | $31.7M | Sell |
327,458
-17,899
| -5% | -$1.69M | 0.37% | 65 |
|
|
2017
Q3 | $30.7M | Sell |
345,357
-82,542
| -19% | -$6.28M | 0.4% | 63 |
|
|
2017
Q2 | $31M | Sell |
427,899
-509
| -0.1% | -$34.2K | 0.42% | 61 |
|
|
2017
Q1 | $27.9M | Sell |
428,408
-21,008
| -5% | -$1.32M | 0.39% | 65 |
|
|
2016
Q4 | $28.1M | Sell |
449,416
-19,265
| -4% | -$1.18M | 0.51% | 45 |
|
|
2016
Q3 | $29.6M | Sell |
468,681
-34,413
| -7% | -$2.23M | 0.53% | 44 |
|
|
2016
Q2 | $31.1M | Sell |
503,094
-50,552
| -9% | -$3.08M | 0.58% | 40 |
|
|
2016
Q1 | $31.6M | Buy |
553,646
+40,464
| +8% | +$2.26M | 0.6% | 39 |
|
|
2015
Q4 | $30.4M | Buy |
513,182
+34,088
| +7% | +$1.96M | 0.59% | 40 |
|
|
2015
Q3 | $26.1M | Sell |
479,094
-27,011
| -5% | -$1.76M | 0.52% | 49 |
|
|
2015
Q2 | $34M | Sell |
506,105
-35,152
| -6% | -$2.29M | 0.63% | 37 |
|
|
2015
Q1 | $31.7M | Sell |
541,257
-224,958
| -29% | -$13.6M | 0.56% | 44 |
|
|
2014
Q4 | $50.6M | Buy |
766,215
+25,558
| +3% | +$1.61M | 0.88% | 16 |
|
|
2014
Q3 | $42.8M | Buy |
740,657
+1,560
| +0.2% | +$86.6K | 0.76% | 26 |
|
|
2014
Q2 | $41.7M | Buy |
739,097
+64,080
| +9% | +$3.36M | 0.77% | 22 |
|
|
2014
Q1 | $34.7M | Buy |
675,017
+443,415
| +191% | +$22.4M | 0.63% | 34 |
|
|
2013
Q4 | $12.2M | Sell |
231,602
-227,650
| -50% | -$11.2M | 0.22% | 122 |
|
|
2013
Q3 | $20.5M | Sell |
459,252
-57,540
| -11% | -$2.55M | 0.39% | 64 |
|
|
2013
Q2 | $21.4M | Buy |
+516,792
| New | +$22.6M | 0.42% | 47 |
|
Other funds holding ABBV
VCM
VPM
Nomura Asset Management's ABBV Position: Q1 2026 in Review
Nomura Asset Management increased its AbbVie (ABBV) stake by 0% in Q1 2026, buying an estimated $9.32K and bringing the position to 1,024,824 shares worth $223M. The position accounts for 0.57% of the portfolio, ranked #27.
Nomura Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $262M in Q1 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Nomura Asset Management held 1,024,824 shares of AbbVie worth $223M as of Q1 2026.
- Nomura Asset Management bought 42 AbbVie shares in Q1 2026, an estimated $9.32K.
- AbbVie made up 0.57% of Nomura Asset Management's portfolio in Q1 2026, its #27 holding.
- Nomura Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Nomura Asset Management's AbbVie position peaked at $262M in Q1 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Nomura Asset Management's 13F filing for Q1 2026, filed 11 May 2026.